BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4080300)

  • 1. Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trial.
    Huber C; Flener R; Gastl G
    Oncology; 1985; 42 Suppl 1():7-9. PubMed ID: 4080300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
    Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
    Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
    S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hairy cell leukemia with alpha interferons.
    Quesada JR; Gutterman JU; Hersh EM
    Cancer; 1986 Apr; 57(8 Suppl):1678-80. PubMed ID: 3948137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies.
    Janssen JT; Ludwig H; Scheithauer W; de Pauw BE; Keyser A; van Tol R; Flener R
    Oncology; 1985; 42 Suppl 1():3-6. PubMed ID: 4080299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
    Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
    Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR; Lepe-Zuniga JL; Gutterman JU
    Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical mycobacterial infection in alpha interferon-treated hairy cell leukaemia.
    Giles FJ; Russell SJ; Worman CP; Goldstone AH; Richards JD; Holton J
    Acta Haematol; 1988; 80(3):159-61. PubMed ID: 3143214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
    Flandrin G; Castaigne S; Sigaux F; Degos L
    Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
    Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F
    Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC; Silber R
    Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha interferon treatment of patients with hairy-cell leukaemia.
    Hagberg H; Alm G; Björkholm M; Glimelius B; Killander A; Simonsson B; Sundström C; Ahre A
    Scand J Haematol; 1985 Jul; 35(1):66-70. PubMed ID: 4048862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha interferons in the treatment of hairy cell leukemia.
    Quesada JR
    Immunobiology; 1986 Sep; 172(3-5):250-4. PubMed ID: 3804367
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
    Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
    Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.